期刊
THERAPEUTIC ADVANCES IN HEMATOLOGY
卷 5, 期 6, 页码 197-210出版社
SAGE PUBLICATIONS LTD
DOI: 10.1177/2040620714552614
关键词
histone deacetylase inhibitor; multiple myeloma; panobinostat
类别
资金
- Novartis
Panobinostat is an investigational and potent histone deacetylase inhibitor (HDACi) that has shown promise as an antimultiple myeloma agent in the preclinical setting. In this review, we discuss the rationale for the use of panobinostat as a combination therapy for multiple myeloma and provide an overview of recent and ongoing clinical trials testing the safety and efficacy of panobinostat for the treatment of the disease.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据